Skin Cancer, Melanoma: References

Content provided by Healthwise

References

Citations

1. Savage P, et al. (2005). Malignant melanoma (non-metastatic). Clinical Evidence (14): 2058–2072.

2. Wang SQ, et al. (2001). Ultraviolet A and melanoma: A review. Journal of the American Academy of Dermatology, 44(5): 837–846.

3. Balch CM, et al. (2005). Cutaneous melanoma. In VT DeVita Jr et al., eds., Cancer: Principles and Practice of Oncology, 7th ed., vol. 2, pp. 1754–1809. Philadelphia: Lippincott Williams and Wilkins.

4. American Cancer Society (2006). Cancer Facts and Figures 2006, pp. 1–56. Atlanta: American Cancer Society. Available online: http://www.cancer.org/docroot/STT/stt_0.asp.

5. Langley RGB, et al. (2003). Neoplasms: Cutaneous melanoma. In IM Freedberg et al., eds., Fitzpatrick's Dermatology in General Medicine, 6th ed., vol. 1, pp. 917–947. New York: McGraw-Hill

6. American Joint Committee on Cancer (2002). Melanoma of the skin. In AJCC Cancer Staging Manual, 6th ed., pp. 209–220. New York: Springer-Verlag.

7. Stern RS, et al. (2001). The risk of melanoma in association with long-term exposure to PUVA. Journal of the American Academy of Dermatology, 44(5): 755–761.

8. National Comprehensive Cancer Network (2006). Melanoma. Clinical Practice Guidelines in Oncology, version 2. Available online: http://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf.

9. National Cancer Institute (2006). Melanoma PDQ: Treatment—Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/melanoma/healthprofessional.

10. Avery RB, et al. (2005). Intraocular melanoma. In VT DeVita Jr et al., eds., Cancer: Principles and Practice of Oncology, 7th ed., vol. 2, pp. 1809–1825. Philadelphia: Lippincott Williams and Wilkins.

11. Martinez J-C, Otley CC (2001). The management of melanoma and nonmelanoma skin cancer: A review for the primary care physician. Mayo Clinic Proceedings, 76(12): 1253–1265.

12. Geller AC, et al. (2002). Use of sunscreen, sunburning rates, and tanning bed use among more than 10,000 U.S. children and adolescents. Pediatrics, 109(6): 1009–1014.

13. Kirkwood JM, et al. (2004). A pooled analysis of Eastern Cooperative Oncology Group and intergroup trials of adjuvant high-dose interferon for melanoma. Clinical Cancer Research, 10(5): 1670–1677.

Last updated:	January 11, 2007
Author:	Shannon Erstad, MBA/MPH
Reviewed By:	Kathleen Romito, MD - Family Medicine, Randall D. Burr, MD - Dermatology
Editors:	Kathleen M. Ariss, MS, Pat Truman, MATC